- Cosmos Health increases its Ethereum holdings to $1.8 million as part of a $300 million digital asset plan.
- CEO Greg Siokas says the company remains committed to accelerating cryptocurrency acquisitions.
- Shares climbed nearly 200% in six months amid Cosmos’ expansion into healthcare and digital finance.
Cosmos Health Inc. (NASDAQ: COSM) has strengthened its digital asset position with a new $300,000 purchase of Ethereum (ETH), bringing the healthcare company’s total investment in the cryptocurrency to $1.8 million.
The move, announced on Monday, is part of the company’s broader $300 million digital asset credit facility designed to diversify its portfolio and support long-term growth.
Headquartered in Chicago and operating across pharmaceutical manufacturing, distribution, and telemedicine, Cosmos Health has become increasingly active in the digital assets space in recent months.
Cosmos Health shares have risen nearly 200% over the past six months.
Strategic expansion through digital assets
The latest Ethereum acquisition highlights Cosmos Health’s commitment to integrating digital assets into its overall financial strategy.
“We continued to add to our Ethereum holdings following last week’s purchase, bringing our total investment in ETH to $1.8 million,” said CEO Greg Siokas.
“We remain committed to accelerating our acquisition program under our $300 million financing facility,” he added, emphasizing the company’s intention to increase exposure to blockchain-based assets.
The move follows a series of earlier cryptocurrency investments made under the same program, first announced earlier this year.
This initiative reflects Cosmos Health’s diversification approach, balancing its core healthcare operations with emerging opportunities in finance and digital technology.
Founded in 2009 and incorporated in Nevada, Cosmos Health operates across several key healthcare sectors, including nutraceuticals, branded pharmaceuticals, and healthcare distribution.
The company’s operations extend to Greece and the United Kingdom, with primary distribution centers located in Thessaloniki, Athens, and Harlow.
Broader strategic developments
Beyond digital assets, Cosmos Health has pursued corporate and operational initiatives to broaden its global footprint.
The company recently announced the appointment of Theodoros C. Karkantzos to its board of directors.
Karkantzos brings more than 15 years of experience in investment and business development and will serve on the Nominating and Corporate Governance Committee.
Additionally, Cosmos Health expanded its Sky Premium Life brand in Kuwait through an exclusive distribution agreement with Diyar United.
Under the agreement, Diyar United will market and distribute the company’s nutraceutical products throughout the Kuwaiti market, further strengthening Cosmos Health’s international presence.
At its most recent annual shareholder meeting, the company also secured approval to increase its authorized shares to 1.5 billion common shares and 300 million preferred shares, a change intended to provide greater financial flexibility.
A diversified path forward
Cosmos Health’s growing commitment to digital assets, and Ethereum in particular, reflects a broader trend among traditional companies exploring blockchain integration and cryptocurrency investments as part of their financial diversification strategies.
While the company’s primary focus remains healthcare and wellness, its entry into digital assets and strategic partnerships signals a forward-looking approach to technology-driven financial management.
With Ethereum holdings now at $1.8 million and a $300 million facility available for further expansion, Cosmos Health appears positioned to continue balancing innovation across healthcare and financial markets while pursuing sustainable long-term growth.